title: Enhanced dissolution rate of felodipine using spherical agglomeration with Inutec SP1 by quasi emulsion solvent diffusion method.
abstract: Felodipine is a second generation calcium channel blocker widely used as antihypertensive and antianginal drug which belongs to BCS class II category. Hence, its low water solubility limits the pharmacological effect. The aim of this study was to improve the dissolution rate of felodipine using spherical agglomeration technique with acetone, water and dichloromethane as good solvent, poor solvent and bridging liquid, respectively. The quasi emulsion solvent diffusion technique was used as a method for spherical agglomeration. Inutec SP1 was used as an emulsion stabilizer and as hydrophilic polymer in agglomeration process. The FTIR and DSC results showed no change in the drug after crystallization process. PXRD studies showed sharp peaks in the diffractograms of spherical agglomerates with minor reduction in height of the peaks. The particle size of spherical agglomerates (FI-2) was about 134.33 ± 13.57 µm, n=3 and the dissolution efficiency of felodipine up to 120 min increased to about 4-fold in phosphate buffer containing 1.8% Tween 80 (pH 6.8). Spherical agglomerates showed enhanced solubility compared to untreated powder possibly due to the partial conversion to amorphous form.
authors: Sudhakarrao Naik Institute of Pharmacy, Pusad-445204, Dist: Yavatmal, Maharashtra, India.
authors: A R
authors: AR
authors: Tapas
authors: P S
authors: PS
authors: Kawtikwar
authors: D M
authors: DM
authors: Sakarkar
references: Acta Pharm. 2007 Jun;57(2):173-84
references: 17507314
references: Science. 1982 Jun 4;216(4550):1127-8
references: 17808500
references: Clin Pharmacokinet. 1991 Dec;21(6):418-30
references: 1782737
references: J Pharm Biomed Anal. 1998 Aug;17(4-5):811-22
references: 9682166
references: Biomacromolecules. 2001 Winter;2(4):1256-9
references: 11777400
references: J Pharm Pharmacol. 1975 Jan;27(1):48-9
references: 235616
references: Eur J Pharm Biopharm. 2000 Jul;50(1):3-12
references: 10840189
references: Drugs. 1988 Oct;36(4):387-428
references: 3069435